Report Detail

Other Global (United States, European Union and China) Neuropeptide Y Receptor Market Research Report 2019-2025

  • RnM3618422
  • |
  • 29 July, 2019
  • |
  • Global
  • |
  • 111 Pages
  • |
  • QYResearch
  • |
  • Other

Neuropeptide Y (NPY) receptors are involved in different types of biological processes. It is a class of G-Protein coupled receptors sensitive to closely associated peptide hormones such as peptide YY, pancreatic polypeptide, and neuropeptide Y. NPY is closely related to central mechanism involving obesity and food intake; however the topic is still a part of extensive medical research.
Increase in prevalence of various diseases related to obesity and surge in overweight populace drives the market.
Moreover, unhealthy urban lifestyle and increase in number of fast food eating populace susceptible to sudden weight gain, is expected to boost the market growth.
However, number of limited manufacturers and distribution channels is anticipated to impede the market growth.
In 2019, the market size of Neuropeptide Y Receptor is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Neuropeptide Y Receptor.

This report studies the global market size of Neuropeptide Y Receptor, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Neuropeptide Y Receptor production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Gila Therapeutics
Novo Nordisk
XL-protein
Lilly Eli
Novartis
Pfizer
Merck & Co
Mannkind
Gilead Sciences
Genentech

Market Segment by Product Type
Food Grade
Pharmaceutical Grade

Market Segment by Application
Medicine
Food Additives
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Neuropeptide Y Receptor status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Neuropeptide Y Receptor manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Neuropeptide Y Receptor are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Neuropeptide Y Receptor Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Food Grade
      • 1.3.3 Pharmaceutical Grade
    • 1.4 Market Segment by Application
      • 1.4.1 Global Neuropeptide Y Receptor Market Share by Application (2019-2025)
      • 1.4.2 Medicine
      • 1.4.3 Food Additives
      • 1.4.4 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Neuropeptide Y Receptor Production Value 2014-2025
      • 2.1.2 Global Neuropeptide Y Receptor Production 2014-2025
      • 2.1.3 Global Neuropeptide Y Receptor Capacity 2014-2025
      • 2.1.4 Global Neuropeptide Y Receptor Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Neuropeptide Y Receptor Market Size CAGR of Key Regions
      • 2.2.2 Global Neuropeptide Y Receptor Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Neuropeptide Y Receptor Capacity by Manufacturers
      • 3.1.2 Global Neuropeptide Y Receptor Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Neuropeptide Y Receptor Revenue by Manufacturers (2014-2019)
      • 3.2.2 Neuropeptide Y Receptor Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Neuropeptide Y Receptor Market Concentration Ratio (CR5 and HHI)
    • 3.3 Neuropeptide Y Receptor Price by Manufacturers
    • 3.4 Key Manufacturers Neuropeptide Y Receptor Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Neuropeptide Y Receptor Market
    • 3.6 Key Manufacturers Neuropeptide Y Receptor Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Food Grade Production and Production Value (2014-2019)
      • 4.1.2 Pharmaceutical Grade Production and Production Value (2014-2019)
    • 4.2 Global Neuropeptide Y Receptor Production Market Share by Type
    • 4.3 Global Neuropeptide Y Receptor Production Value Market Share by Type
    • 4.4 Neuropeptide Y Receptor Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Neuropeptide Y Receptor Consumption by Application

    6 Production by Regions

    • 6.1 Global Neuropeptide Y Receptor Production (History Data) by Regions 2014-2019
    • 6.2 Global Neuropeptide Y Receptor Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Neuropeptide Y Receptor Production Growth Rate 2014-2019
      • 6.3.2 United States Neuropeptide Y Receptor Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Neuropeptide Y Receptor Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Neuropeptide Y Receptor Production Growth Rate 2014-2019
      • 6.4.2 European Union Neuropeptide Y Receptor Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Neuropeptide Y Receptor Import & Export
    • 6.5 China
      • 6.5.1 China Neuropeptide Y Receptor Production Growth Rate 2014-2019
      • 6.5.2 China Neuropeptide Y Receptor Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Neuropeptide Y Receptor Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Neuropeptide Y Receptor Consumption by Regions

    • 7.1 Global Neuropeptide Y Receptor Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Neuropeptide Y Receptor Consumption by Type
      • 7.2.2 United States Neuropeptide Y Receptor Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Neuropeptide Y Receptor Consumption by Type
      • 7.3.2 European Union Neuropeptide Y Receptor Consumption by Application
    • 7.4 China
      • 7.4.1 China Neuropeptide Y Receptor Consumption by Type
      • 7.4.2 China Neuropeptide Y Receptor Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Neuropeptide Y Receptor Consumption by Type
      • 7.5.2 Rest of World Neuropeptide Y Receptor Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Gila Therapeutics
      • 8.1.1 Gila Therapeutics Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Neuropeptide Y Receptor
      • 8.1.4 Neuropeptide Y Receptor Product Introduction
      • 8.1.5 Gila Therapeutics Recent Development
    • 8.2 Novo Nordisk
      • 8.2.1 Novo Nordisk Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Neuropeptide Y Receptor
      • 8.2.4 Neuropeptide Y Receptor Product Introduction
      • 8.2.5 Novo Nordisk Recent Development
    • 8.3 XL-protein
      • 8.3.1 XL-protein Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Neuropeptide Y Receptor
      • 8.3.4 Neuropeptide Y Receptor Product Introduction
      • 8.3.5 XL-protein Recent Development
    • 8.4 Lilly Eli
      • 8.4.1 Lilly Eli Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Neuropeptide Y Receptor
      • 8.4.4 Neuropeptide Y Receptor Product Introduction
      • 8.4.5 Lilly Eli Recent Development
    • 8.5 Novartis
      • 8.5.1 Novartis Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Neuropeptide Y Receptor
      • 8.5.4 Neuropeptide Y Receptor Product Introduction
      • 8.5.5 Novartis Recent Development
    • 8.6 Pfizer
      • 8.6.1 Pfizer Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Neuropeptide Y Receptor
      • 8.6.4 Neuropeptide Y Receptor Product Introduction
      • 8.6.5 Pfizer Recent Development
    • 8.7 Merck & Co
      • 8.7.1 Merck & Co Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Neuropeptide Y Receptor
      • 8.7.4 Neuropeptide Y Receptor Product Introduction
      • 8.7.5 Merck & Co Recent Development
    • 8.8 Mannkind
      • 8.8.1 Mannkind Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Neuropeptide Y Receptor
      • 8.8.4 Neuropeptide Y Receptor Product Introduction
      • 8.8.5 Mannkind Recent Development
    • 8.9 Gilead Sciences
      • 8.9.1 Gilead Sciences Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Neuropeptide Y Receptor
      • 8.9.4 Neuropeptide Y Receptor Product Introduction
      • 8.9.5 Gilead Sciences Recent Development
    • 8.10 Genentech
      • 8.10.1 Genentech Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Neuropeptide Y Receptor
      • 8.10.4 Neuropeptide Y Receptor Product Introduction
      • 8.10.5 Genentech Recent Development

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Neuropeptide Y Receptor Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Neuropeptide Y Receptor Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Neuropeptide Y Receptor Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Neuropeptide Y Receptor Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Neuropeptide Y Receptor Production Forecast by Type
      • 9.7.2 Global Neuropeptide Y Receptor Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Neuropeptide Y Receptor Sales Channels
      • 10.2.2 Neuropeptide Y Receptor Distributors
    • 10.3 Neuropeptide Y Receptor Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Summary:
      Get latest Market Research Reports on Neuropeptide Y Receptor . Industry analysis & Market Report on Neuropeptide Y Receptor is a syndicated market report, published as Global (United States, European Union and China) Neuropeptide Y Receptor Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Neuropeptide Y Receptor market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,584.64
      3,876.96
      5,169.28
      3,017.60
      4,526.40
      6,035.20
      510,433.60
      765,650.40
      1,020,867.20
      273,486.40
      410,229.60
      546,972.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report